ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

2021 American Transplant Congress

June 4-9, 2021

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

View by Title View Sessions View Topics
View by Date
Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z
  • Calcineurin Inhibitor Dose and Selection, Not Antiproliferatives or Steroids, Influence Development of DSA One Year Post-kidney Transplant

    M. Henderson1, G. Morris2, L. Awdishu1, K. Fabbri1, M. Shah3, A. Khan3, J. Kerr1

  • Can an Organ Survive for More Than 100 Years Between Donor and Recipient

    R. Gruessner, J. Renz, A. C. Gruessner

  • Can Procurement Biopsy Data Tell Us Anything? The Influence of Glomerulosclerosis on Long-term Kidney Graft Survival

    D. Stewart1, L. Kamal2, J. Foutz3, H. McGehee3, P. Saravanane2, S. Yu2, R. Yousfi2, G. Gupta2

  • Can Procurement Biopsy Data Tell Us Anything? The Influence of Interstitial Fibrosis on Long-term Kidney Graft Survival

    D. Stewart1, J. Foutz1, L. Kamal2, H. McGehee1, P. Saravanane2, S. Yu3, R. Yousfi2, G. Gupta2

  • Cancer Among Kidney Transplant Recipients More Than 20 Years After Transplantation: PTLD Remains the Most Common Cancer Type Even in the Very Long-Term

    T. Schachtner, J. Fuhrmann, T. Mueller

  • Cancer-Specific Mortality in Solid Organ Transplant Recipients with a Prior Cancer Diagnosis

    E. Engels1, G. Haber1, A. Hart2, C. Lynch3, J. Li4, K. Pawlish4, B. Qiao5, K. Yu1, R. Pfeiffer1

  • Cardiac Outcomes in Isolated Heart and Simultaneous Kidney and Heart Transplants in the US

    K. A. Agarwal1, H. Patel1, N. Agrawal1, F. Cardarelli1, N. Goyal2

  • Cardiac Risk Assessment in Liver Transplant Candidates: Survey of National Practice Patterns

    P. Barman1, R. Chadha2, L. VanWagner3

  • Caspase-3 is a Predominant Regulator of Microvascular Dysfunction and Aki-ckd Transition Post Renal Ischemia-reperfusion Injury

    S. Lan, F. Migneault, J. Turgeon, M. Bourgault, M. Dieudé, N. Patey, H. Cardinal, M. Hébert

  • Cd4 T Cells Can Trigger Nk-dependent Chronic Rejection Independent of Antibodies

    R. G. Gill1, B. Mehrad2, C. M. Lin2

  • CD40 Blockade by the Fc-Silent Immunosuppressive Antibody Iscalimab Results in Diminished B Cell Activation and Differentiation and is Paralleled by Whole Blood Gene Expression Data

    R. Kraaijeveld1, M. W. van den Hoogen1, A. E. de Weerd1, E. Ferroro2, G. Robert2, U. Laessing2, B. Haraldsson2, J. S. Rush2, C. C. Baan1

  • CD40/40L Pathway is Critical in Controlling CMV Transmission Following Kidney Transplantation in Immunocompromised Mice

    X. Lai1, L. Qiu2, J. Wang1, L. VanOsdol1, S. Yan3, M. Kandpal4, M. Abecassis5, Z. Zhang1

  • CD47-Mediated Gli1/Notch1 Signaling is a Key Regulator of Mesenchymal Stem Cell Immunomodulation in Liver Inflammatory Injury

    D. Xu, M. Sheng, Y. Lin, Y. Tian, Y. Zhan, C. Li, A. J. Coito, R. W. Busuttil, D. G. Farmer, J. W. Kupiec-Weglinski, B. Ke

  • CD56dimCD16bright NK Cells from Kidney Transplant Recipients with Antibody-mediated Rejection Display Increased Proliferation, Type-1 Activation and Cytotoxic Profile

    E. Bailly1, C. Macedo1, K. Louis1, B. Ramaswami1, M. Lucas1, C. Bentlejewski1, P. Randhawa1, A. Zeevi1, C. Lefaucheur2, D. Metes1

  • CD80/PD-L1 Uniquely Regulates CD4 Effector T Cell Migration

    W. Piao1, L. Li1, Y. Zhang2, K. Hippen2, M. WillsonShirkey1, B. Blazar2, L. Riella3, J. Bromberg1

  • CEACAM1 Signaling is Essential to Elicit Tim-3 Inhibitory Regulation in Liver Transplantation

    H. Kojima, H. Hirao, T. Ito, K. Kadono, K. J. Dery, F. M. Kaldas, J. W. Kupiec-Weglinski

  • Cellular and Genetic Signatures of Operational Tolerance in Kidney Transplant Recipients Through Single Cell R N A Sequencing Analysis

    H. BAE1, H. Lee2, J. Ryu3, B. Chung2, E. Oh3

  • Cellular Landscape of Steatotic Livers Revealed by Single-nuclei Rna Sequencing

    C. Kuscu1, C. Kuscu1, A. Shetty2, E. Bardhi3, T. Rousselle4, J. Eason1, M. Sraj5, D. Maluf6, V. Mas4

  • Center Cost is Not a Barrier to Aggressive Utilization of DCD Livers

    L. M. Brewer, D. M. Faulkner, A. J. Logan, J. M. Sneddon, G. N. Brock, N. Singh, W. K. Washburn, A. D. Schenk

  • Center Use of Technical Variant Grafts Impacts Pediatric Liver Transplant Waitlist and Recipient Outcomes in the United States

    G. Mazariegos1, E. R. Perito2, J. Squires1, K. Soltys1, A. Griesemer3, S. A. Taylor4, E. Pahl5

  • Centers Avoided 67% of Kidney Offers by Participating in the OPTN’s Multifactorial Offer Filter Pilot Project

    A. Toll, H. McGehee, D. Stewart, R. McTier

  • Centre Variation in Emergency Hospital Readmissions Following Renal Transplantation in England

    J. Peracha1, D. Pitcher1, R. Steenkamp1, J. Medcalf2, G. Lipkin3, D. Nitsch4, W. McKane5

  • Challenges and Stressors of COVID-19 Kidney and Transplant Patients: A Mixed Methods Study

    Y. A. Iraheta1, A. L. Murillo2, E. H. Wood1, S. M. Advani3, R. Pines4, A. D. Waterman1

  • Chances of Renal Recovery in Liver Only Transplant Recipients Who Were Eligible for Simultaneous Liver-Kidney Transplant

    J. Cui1, A. Spann2, A. Shingina2, H. M. Schaefer3, J. C. Slaughter4, S. Alexopoulos5, M. Izzy2

  • Change in Deceased Donor Demographics with Drug Intoxication Deaths: 2010 – 2019

    D. Musgrove, D. Zaun, A. Israni, J. Snyder

  • Changes in Body Mass Index Before and After Kidney Transplant

    M. Laub1, S. Finder2, P. Harikrishnan1, M. Simon3, I. Gani1, M. Saeed1, R. Kapoor1

  • Changes in Cytomegalovirus Specific T Cell Immunity With Immunomodulation in Serodiscordant High Risk Transplant Recipients

    T. Tinkham, C. Song, R. Winstead, I. Yakubu, A. Brown, S. Sterling, G. Gupta, D. Kumar

  • Changes in Glomerular Filtration Rate (delta Egfr) within the First Year Predict Long-Term Outcomes of Renal Grafts

    A. M. Thompson, M. Zenati, S. Hariharan, M. Molinari

  • Changes in Liver Transplant Volume and Induction During the Covid-19 Era

    T. Alhamad, J. Wellen, K. Lentine, M. Doyke, W. Chapman, Y. Al-Hosni, D. Axelrod, S. Chang

  • Changes to Adult Heart Allocation Improve Candidate Stratification

    K. Bradbrook1, K. Lindblad1, R. R. Goff1, R. Daly2, S. Hall3

  • Changes to Allocation of En Bloc Deceased Donor Kidneys to Low Epts Patients

    A. Robinson1, M. Pavlakis2, V. Casingal3

  • Characterisation of Distinct Graft Infiltrates Following Cellular Therapy in Kidney Transplant Recipients

    M. O. Brook1, P. N. Harden2, I. Roberts2, W. R. Mulley3, J. Hester1, M. E. Reinders4, F. Issa1

  • Characteristics, Risk Factors, and Outcomes of Neutropenia for the First Year After Liver or Kidney Transplantation in Children

    C. Jarasvaraparn1, S. Choudhury2, C. Rusch2, K. Liss1, J. Stoll1, S. Hmiel3, S. Kulkarni1

  • Characterization of Chronic Renal Allograft Dysfunction at Single Cell Resolution

    C. Kuscu1, C. Kuscu2, A. Shetty3, M. Talwar4, J. Eason2, D. G. Maluf5, V. Mas6

  • Characterization of Kidney Small Extracellular Vesicles Released During Normothermic Machine Perfusion

    W. W. Woud1, A. Arykbaeva2, D. de Vries2, I. Alwayn2, K. Boer1, C. Baan1, M. Hoogduijn1, R. Minnee3

  • Characterization of Retransplantation Following Graft Failure Due to Bkvn

    K. Nguyen1, H. Curtis2, J. Panichella2, H. Resweber3, A. Di Carlo2, S. Karhadkar1

  • Characterization of SGLT2 Inhibitor Use After Abdominal Transplant

    F. Hailemariam1, S. Yeager2, J. Schulte3, P. Singh1, A. Yadav1

  • Characterizing Kidney Transplant Recipients with SARS-CoV-2: An Academic Single Center Experience

    S. Nahi, A. Shetty, S. Tanna, J. Leventhal

  • Characterizing the Early Impact of the Kidney Accelerated Placement Project on Hard-to-place Kidneys

    J. D. Motter, A. Kernodle, M. Levan, D. Segev, J. Garonzik-Wang, A. Massie

  • CHBP Induces Stronger Immunosuppressive CD127+ M-MDSC via Erythropoietin Receptor

    C. Yang

  • Classification of Distinct Patterns of Ischemic Cholangiopathy Following DCD Liver Transplantation: Distinct Clinical Courses and Long-Term Outcomes from a Multicenter Cohort

    K. P. Croome1, A. K. Mathur2, B. Aqel2, L. Yang1, J. K. Heimbach3, T. Taner3, C. B. Rosen3, R. Paz-Fumagalli1, C. Taner1

  • Clazakizumab (clz, Anti-il-6 Antibody) Treatment Affects Il-6/il-6r Signaling by Increasing Soluble Gp130 (sgp130) in Hla-sensitized Kidney Transplant Patients (hs Ktx Pts) Treated for Chronic Antibody-mediated Rejection (cabmr)

    B. Shin, S. Ge, A. Jimenez, N. Ammerman, A. Vo, R. Zhang, S. C. Jordan, M. Toyoda

  • Clazakizumab for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: Phase 3 IMAGINE Study Design

    P. Nickerson1, G. Böhmig2, S. Chadban3, D. Kumar4, R. B. Mannon5, T. van Gelder6, S. Adler7, E. Chong7, A. Djamali8

  • Clearance of Viral RNA and DNA and Antibody Response Following Administration of Live Attenuated Measles and Varicella Vaccines in Children with Chronic Liver Disease

    S. Kemme1, A. Weinberg2, A. G. Feldman1

  • Cleveland Clinic Experience with Cadaveric Uterus Transplant

    L. Del Prete1, C. Quintini1, K. Hashimoto1, B. Eghtesad1, G. D'Amico1, C. Kwon1, D. Priebe1, E. Richards1, S. Ricci1, U. Perni1, C. Ferrando1, A. Chiesa-Vottero1, S. Mawhorter1, N. Yeaney1, R. Farrell1, R. Flyckt2, C. Miller1, T. Falcone1, A. Tzakis1

  • Clinical Analysis of the Prognosis After Receiving a Liver Graft That Abandoned Transplantation Due to Poor Graft Conditions in the Centers Allocated as a Priority

    H. Choi1, G. Na2

  • Clinical and Molecular Profiling Can Help in Predicting the Response to Alemtuzumab Treatment in Kidney Transplant Recipients with Severe or Glucocorticoid-Resistant Acute Rejection

    D. M. Peelen1, M. van der Zwan1, M. C. Clahsen-van Groningen2, D. A. Mustafa2, C. C. Baan1, D. A. Hesselink1

  • Clinical and Pathological Features of Lobar Nephronia in Renal Allograft

    Y. Wang1, Z. Yan1, Y. Liu1, Y. Zhou1, Y. He1, W. Zeng1, R. Xia1, W. Deng1, J. Xu1, C. Wu2, Y. Miao1

  • Clinical Characteristics and Outcomes of Aspergillus Infections in Intestinal Transplant Patients: Retrospective Cohort Study

    A. Fernandez, M. Romero, Y. Natori, J. Camargo, S. Anjan, R. Vianna, J. Simkins

  • Clinical Characteristics, Risk Factors and Outcomes of Norovirus Infection in Renal Transplant Patients: A Retrospective Single Center Study

    T. Brooks1, T. Crilley1, B. Gaglani2, N. Jakharia2

  • Clinical Consequences in Patients Experiencing Leukopenia and Neutropenia After Solid Organ Transplant

    A. Diamond1, N. Diehl2, K. Hiryak3, K. Mortia1, J. Au1, C. Ruggia-Check1, H. Clauss4

  • Clinical Correlation of Frailty Measures and Evaluation of Complementary Molecular Frailty Biomarker Candidates in a Prospective National Cohort of Liver Transplant Candidates

    S. Cremen1, M. Robinson2, T. Gallagher1

  • Clinical Course and Outcomes in Solid Organ Transplant Recipients with Covid-19

    R. C. Jackson1, S. Challa2, A. Halim1, N. Kelly3, D. Maluf4, K. Shetty3, Z. Lominadze3

  • Clinical Effect of Post-transplant Av-fistula Ligation on Hemodynamic Status and Kidney Allograft Function

    S. Valavoor, J. Powelson, A. Sharfuddin, O. Adebiyi

  • Clinical Features and Outcomes of Candidemia in Patients with Left Ventricular Assist Devices

    G. Krishnan, Y. Hamad, I. George

  • Clinical Impact of Transplant Pharmacists on the Care of Solid Organ Transplant Recipients

    I. Shah1, J. Au1, A. Diamond1, N. Sifontis2, C. Ruggia-Check1

  • Clinical Outcomes and Management of Covid-19 Patients Among Kidney Transplant Recipients: A Systematic Review

    S. Ismail1, A. Babonj2, S. Al Harbi3, A. Babonj2, A. Almalki1, E. J. Murray4

  • Clinical Outcomes and Racial Impact of HLA Matching in the Australian Deceased Donor Kidney Transplantation Program, 2000-2018

    M. Gramlick, M. Heer

  • Clinical Outcomes Associated with Induction Therapy Regimens for Kidney Transplantation in Children: A NAPRTCS and PHIS Collaborative Report

    H. Pizzo1, D. Levy Erez2, N. M. Rodig3, T. Richardson4, M. Somers3

  • Clinical Outcomes of Culture-Positive Pneumonia in Solid Organ Transplant Recipients

    L. Rice1, A. C. Kalil2, D. Hixson2, M. Leick3

  • Clinical Outcomes of Living Kidney Transplantation from Elderly Spousal Donors

    Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika

  • Clinical Outcomes of Solid Organ Transplant Recipients Treated with Remdesivir and Convalescent Plasma for Covid-19 at the Largest Transplant Center in the United States

    A. Fernandez, S. Anjan, A. Chandorkar, D. de Lima, R. Zamora, L. A. Mendez-Castaner, J. Simkins, J. Camargo, M. Morris, M. Loebe, J. Bauerlein, C. O’Brien, N. Sinha, G. Burke, G. Ciancio, A. Mattiazzi, R. Vianna, L. Abbo, G. Guerra, Y. Natori

  • Clinical Outcomes of Solid Organ Transplant Recipients with Severe Acute Respiratory Syndrome Coronavirus 2

    R. Adekunle, D. Jandhyala, J. Lewis

  • Clinical Signs Predictive of Covid-19 Mortality Among Transplant Recipients

    D. Ginzberg1, K. Pierce2, E. Kreiger-Benson2, M. Graves2, H. Neumann3, N. Ali3, C. Gidea3, J. Park3, S. Mehta3

  • Clinical Validation and Performance of Donor-Derived Cell-Free DNA in Allograft Rejection

    S. Anand1, A. Pai2, J. S. Bromberg3, G. Gupta4, I. Moinuddin4, T. Alhamad5, V. Bowers6, S. Ghosh7, W. Tian7, L. Bu8, E. Stites9

  • Clinical Value of Surveillance Biopsies in Pediatric Liver Transplantation: A Single Center Experience with >800 Biopsies

    B. Rocque1, A. Zaldana1, C. Weaver2, J. Huang1, A. Barbetta1, V. Shakhin2, C. Goldbeck1, G. Yanni2, R. Kohli2, Y. Genyk1, J. Emamaullee1

  • Clinically Evident Portal Hypertension (CEPH) is Associated with Low IGF-1 in Children with Chronic Liver Disease

    B. Whitehead1, S. Mohammad1, S. Kelly1, J. Josefson2, L. Mithal3, E. M. Alonso1

  • Cmv Specific Cellmediated Immune Reconstitution During Letermovir Prophylaxis in High Risk Hematopoietic Cell Transplant Recipients

    M. Abidi1, J. Gutman2, A. Weinberg2

  • Coexistence of BKPyV Lytic Infection and Viral Integration in the Development of BKPyV Diseases After Renal Transplantation

    S. Yan1, Y. Wang1, Y. Liu1, W. Deng1, Z. Yan1, J. Xu1, C. Wu2, Y. Miao1

  • Cognition After Belatacept Conversion (CAB) Trial

    W. Asch1, K. Belfield2, V. Do2, E. Cohen1

  • Cold Perfusion for Ischemia Minimization Reduces Cardiac Injury in an Ex Vivo Xenoperfusion Model

    M. R. Connolly1, A. Calhoun1, F. Pollok1, L. Burdorf1, Z. Habibabady1, M. Ma1, S. Miura1, W. Eyestone2, C. Phelps2, D. Ayares2

  • Combined CD11b/CD40 Blockade is Superior to CD40 Blockade Alone in Prolonging Survival in Pig-to-Nonhuman Primate Renal Xenotransplantation

    D. A. Faber1, B. Lovasik1, A. Matar1, C. Breeden1, S. Kim1, A. Adams2

  • Combined Donor Derived Cell Free DNA (AlloSure) and Peripheral Immune Cell Gene Expression (AlloMap) Testing for the Diagnosis of Rejection in Kidney Transplant Recipients with De Novo Donor Specific Antibodies

    K. R. Degner, S. Parajuli, F. Aziz, N. Garg, D. Mandelbrot, M. Mohamed, K. Van Hyfte, S. R. Reese, N. A. Wilson, A. Djamali

  • Combined Heart-liver Transplantation in Patients with Familial Amyloidosis – Analysis of Optn/Unos Database

    A. Sharma, A. Sickels, B. Ruch, M. Carli, M. Levy

  • Combined Impact of Pre-sensitization and Delayed Graft Function on Allograft Rejection in Deceased Donor Kidney Transplantation: A Nationwide Cohort Study

    H. Lee1, Y. Park1, T. Ban2, S. Song3, S. Song4, J. Yang5, C. Ahn5, C. Yang1, B. Chung1

  • Combined Liver and Lung Transplantation with Extended Normothermic Liver Preservation Using Transmedics Organ Care System (OCS)TM Liver: A Single Center Experience

    J. Konel1, M. Shamaa2, O. Shamaa2, A. Elsabbagh2, T. Kitajima2, T. Ivanics2, K. Delvecchio2, A. Mohamed2, S. Yeddula2, K. Collins2, A. Yoshida2, M. Abouljoud2, S. Nagai2, M. Rizzari2

  • Combined Liver-Kidney Transplantation in Adults With End-Stage Liver Disease: Risk Factors in Patients with Chronic Kidney Disease Stages 3-5, Not on Maintenance Dialysis

    A. Santos, E. Bueno, M. Leghrouz

  • Combining Oxygenated Cold Perfusion with Normothermic Ex-vivo Perfusion Improves the Outcome of DCD Porcine Kidney Transplantation

    L. I. Mazilescu1, T. Goto1, R. Rosales1, Y. Noguchi1, P. Urbanellis1, L. A. Robinson2, M. Selzner1

  • Comorbidity Burden is Associated with Increased Waitlist Mortality Among NASH Patients

    J. R. Montgomery1, M. J. Englesbe1, C. Connelly2

  • Comparative Outcomes of Endovascular Interventions for Hepatic Artery Stenosis Following Adult Liver Transplantation

    S. Desai1, D. Crabtree2, A. Parsikia2, R. Ahuja1, A. Desai1, B. Natarajan1, P. Brady1, H. Kaul3, K. Khanmoradi3, R. Zaki3, N. Chandolias3

  • Comparative Outcomes of TPIAT in African American and Caucasian Patients with Chronic Pancreatitis

    M. A. Kanak, J. B. Spriggs, P. Coughenour, J. Kalivarathan, P. Saravanan, M. F. Levy

  • Comparative Proteomics Analysis Identifies the Biomarker of Ischemia-Reperfusion Injury During Liver Transplantation

    M. Chen1, L. Xiaohong2, H. Xitao1, J. Weiqiang1

  • Comparing Bortezomib Protocol versus IVIG/Rituximab in the Treatment of Antibody Mediated Rejection (AMR) in Kidney Transplantation

    V. M. Lowery1, A. Centeno1, T. Harrison1, P. Cabrera1, A. Mattiazzi2

  • Comparison of Allograft Outcomes in SLK Transplant Patients with and without ESLD: A UNOS Database Analysis

    P. Kyriazis, H. Patel, P. Nissaisorakarn, F. Cardarelli, N. Agrawal

  • Comparison of Donor-derived Cell Free Dna Between Recipients with First Solitary Allograft and Regrafts

    S. Paluri1, S. Muthusamy1, M. Shinbashi1, G. Gupta1, B. Dale2, Z. Kashi3, P. Halloran4, D. Kumar1

  • Comparison of Kidney Transplantation Outcomes Between Donors After Controlled Circulatory Death and Brain Death Donors in Catalonia, Spain

    J. Juega1, M. Pérez-Sáez2, J. Comas3, A. Zapatero4, M. Crespo2, J. Tort3, R. Lauzurica1, J. Pascual2

  • Comparison of Next Generation Sequencing Donor-derived Cell Free DNA Assay Utilizing Whole Genome Sequencing

    N. Singh1, M. S. Naseer1, D. Aultman2, H. Shokouh-Amiri2, G. Zibari2

  • Comparison of Outcomes in Sot Recipients During Two Eras of Covid-19 Therapeutics

    T. Chiang, A. Sait, A. Massie, K. Marr, D. Brennan, W. Cochran, P. Shah, T. Jain, S. Mehta Steinke, N. Desai, N. Permpalung, S. Shoham, C. Merlo, C. Durand, W. Werbel, M. Dioverti, D. Ostrander, A. Gurakar, M. Y. Kim, J. Garonzik-Wang, D. Segev, R. Avery

  • Comparison of Outcomes of Hepatitis C Virus (hcv) Nucleic Acid (nat) Positive Donor Between Hcv-naïVe and Hcv + Recpients – A Donor Mate Analysis

    J. Kamal, B. Sharma, A. Doyle, A. Kumar, A. Nishio-Lucar, S. Rao

  • Comparison of Outcomes of Living Donor Liver Transplantation for Biliary Atresia Patients with and without Kasai Portoenterostomy

    T. Kanmaz1, O. Andacoglu1, Y. Yankol2, C. Karatas1, N. Mecit1, K. Acarli3, M. Kalayoglu1

  • Compatible Paired Donation in Paired Kidney Exchange: A Look at the Road Not Taken

    G. Vranic, A. Gilbert, B. Thomas, S. Ghasemian, M. Cooper, J. Verbesey

  • Complement Blockade Improves Renal Xenograft Survival in Primates in the Absence of Transgenic Complement Regulatory Proteins

    D. A. Faber1, B. Lovasik1, A. Matar1, C. Breeden1, A. B. Farris2, M. Tector3, A. Tector3, A. Adams4

  • Composition of Ex Vivo Lung Perfusion Solutions and Kinetics Define Differential Cytokine and Chemokine Secretion in a Porcine Cardiac Arrest Model of Lung Preservation

    L. M. Radomsky1, A. Koch2, C. Olbertz2, J. F. Kuehne1, Y. Liu2, J. Keil1, K. Beushausen1, U. Rauen3, C. S. Falk1, M. Kamler2

  • Comprehensive Intrahepatic Biliary Anatomy Underscores the Split-ability and the Origin of Biliary Leakage in Hemiliver Split Liver Transplant

    J. Nguyen1, K. Musto1, M. Dougherty1, R. Paz-Fugamalli2, D. Harnois1

  • Comprehensive Utilization of HCV Viremic and Non-Viremic Donor Livers and Kidneys into HCV-negative Patients

    M. E. de Vera, J. Woloszyn, J. Sterris, M. Robinson, R. Evans, S. Blais, B. Elhazin, C. Amador, c. Berk, M. Volk, R. Villicana

  • Construction of a Waiting Time Predictive Model for Kidney Transplant with Deceased Donor in the State of São Paulo

    J. Silva1, M. Contti1, M. Valiatti1, H. Nga1, G. Santos1, M. Perosa2, G. Ferreira3, L. Modelli de Andrade1

  • Continuation of Immunosuppression After the First Renal Allograft Failure Impacts Panel Reactive Antibody Status During Subsequent Renal Transplantation

    J. Patel1, S. Ali2, M. L. Sanders3, C. P. Thomas3, D. Axelrod3, M. Bilal4, E. H. Field4, S. Kuppachi3

  • Continuous 24-Hour Antithymocyte Globulin (ATG) for Renal Allograft Rejection: Results of a Randomized Controlled Trial

    S. J. Patel, A. Rogers, S. Kuten, R. Knight, E. Graviss, D. Nguyen, T. Ellimuttil, I. Agboli, L. Gaber, A. Gaber

  • Contribution of T-bet Expressing CD27+ CD21- Activated Memory B Cells Poised for Plasma Cell Differentiation to Antibody-mediated Rejection of Kidney Transplants

    K. Louis1, E. Bailly1, C. Macedo1, B. Ramaswami1, X. Gu1, G. Chalasani1, A. Zeevi1, P. Randhawa1, H. Singh2, C. Lefaucheur3, D. Metes1

  • Controlled Donation After Circulatory Death Pancreas Transplantation in Spain. Initial Experience

    J. Ferrer-Fàbrega1, R. Muñoz2, J. Ruiz3, D. Casanova4, F. Sánchez-Bueno5, J. Pérez-Daga6, C. Fernández-Rivera7, M. Gómez8, F. Castillo9, R. López-Andújar10, J. Maupoey10, J. Briceño11, J. Sánchez-Hidalgo11, Á. Arjona11, A. Álvarez12, A. Alarcó13, A. Bravo13, R. García1, R. Rull1, M. López-Boado1, P. Ventura-Aguiar14, F. Diekmann14, D. Paredes15, J. García-Valdecasas1, J. Fuster1, C. Fondevila1, B. Domínguez-Gil2

  • Conversion from Tacrolimus to Envarsus in Rapid Metabolizers for Prevention of BK Infection

    G. Towns, G. Agarwal, C. Kew

  • Conversion to Belatacept Based Immunosuppression Regimen in Kidney Transplant Patients: Lessons Learned

    R. Saidi, N. Huang, C. Yang, I. Movileanu, K. Ecal, A. Senay, O. Pankewycz, R. Dvorai, R. Shahbazov, M. Laftavi

  • Core Signature of Rejection-Specific Cytokines and Chemokines in Heart Biopsies After Transplantation

    L. M. Radomsky1, Y. Scheibner2, J. F. Kuehne1, J. Keil1, K. Beushausen1, K. Ludmilla2, A. Schick2, F. Ius2, G. Warnecke3, C. Bara2, C. S. Falk1

  • Coronary Computed Tomography Angiography for Pre-Liver Transplant Cardiovascular Risk Assessment: A Single Center Experience

    J. Rice1, T. Genders2, D. Groves2, J. R. Burton1, J. Moloo2, R. Quaife2, D. Vargas3, M. Kriss1

  • Correlation of Coronary Anatomy and Interventions with Post-kidney Transplantation Outcomes

    A. Sharma, T. Teigeler, D. Kumar, S. Moldowan, C. Bhati, G. Gupta, L. Kang, M. Levy

  • Corticosteroid Reintroduction in Urban Simultaneous Kidney-pancreas Transplant Recipients Following an Early Corticosteroid Withdrawal Protocol

    D. Pierce, P. West-Thielke, M. Campara, I. Tang, M. Spaggiari, I. Tzvetanov, E. Benedetti, A. Lichvar

  • Cost Effectiveness Analysis Comparing Treatments of Biliary Strictures in Pediatric Liver Transplant Patients

    B. Whitehead1, C. Lemoine2, R. Superina2, J. Green3, S. Mohammad1

  • Cost Savings Initiative with Idea Body Weight Dosing of Rabbit Anti-thymocyte Globulin (rATG) Induction in an Older Kidney Transplant Population: A Single Center Analysis

    C. LaFratte1, S. Witek1, D. Sawinski2, J. Trofe-Clark2, C. Sammons2, B. Hardek1, R. Samudralwar1, A. Forte1, S. Lyle1, J. Rashid1, G. Malat2

  • Cost-Effectiveness Analysis of Short-Duration Anti-Viral Prophylaxis for Hepatitis C Positive Donor Kidney Transplants

    I. Yakubu, Y. Zhang, S. Ijioma, N. V. Carroll, J. Patterson, R. Sterling, G. Gupta

  • Covid 19 Re-infection versus Re-activation in Two Renal Transplant Patients

    L. Liriano-Ward, Y. Al Azzi, R. Bartash, C. Pynadath, M. Ajaimy, P. Loarte, J. Graham, S. Greenstein, M. Kinkhabwala, J. Rocca, E. Akalin

  • Covid Infection Among Kidney Transplant Recipients: Management and Outcomes

    A. Price, K. Soliman, C. Zayas, V. Rao, M. Casey, D. Taber, M. Posadas Salas

  • Covid Studies in 208 Patients with Consent for Donation

    A. L. Friedman, C. Ezzell, K. Delli Carpini

  • Covid vs Non Covid Pneumonia in Kidney Transplant Recipients

    R. Prashar, N. Khoury, P. Shrivastava, S. Yeddula, T. Kitajima, E. Ulrich, M. Ramesh, A. Patel, S. Nagai, M. Samaniego-Picota

  • Covid-19 Caseload and Management Practices Vary by Program-Level Factors: A Multinational Survey Study

    S. Sandal1, B. Boyarsky2, P. Chiang2, A. Massie2, D. Segev2, M. Cantarovich1

  • Covid-19 Impact of the Pandemic Surge on Patients Waiting for Renal Transplantation at a Single New York City Transplant Center

    G. Boyd, D. Tsapepas, R. Bonifacio, L. Brinkers, C. Brennan, A. Chang, M. Dalangin, L. Lowe, J. K. Mendoza, J. V. Mendoza, C. McNulty, M. Morris, M. Muttiah, K. Nickason, L. Ratner

  • Covid-19 in a Kidney Transplant Patient Associated with Collapsing Glomerulopathy

    W. Hninn, M. Merzkani, H. Murad, A. Malone, A. Java, G. Rajashekar, R. Delos Santos, T. Alhamad

  • Covid-19 in Hiv-infected Solid Organ Transplant Recipients: A Case Series

    M. Ramanathan, A. Fernandez, Y. Natori, J. Simkins, J. Camargo, M. Morris, N. Rivera, M. Loebe, G. Ciancio, L. Abbo, A. Mattiazzi, G. Guerra, S. Anjan

  • COVID-19 in Hospitalized Kidney Transplant Recipients: Clinical Course, Prognostic Factors and Differences Between First and Second Waves

    N. Macías, M. Rodríguez Ferrero, A. Acosta, J. Carbayo, Á. González Rojas, A. Muñoz de Morales, A. García Prieto, M. Goicoechea

  • COVID-19 in Kidney Transplant Recipients in the Southeastern United States: A Single Center Experience

    K. R. Kumm, S. H. Shawar, R. C. Forbes, B. P. Concepcion

  • Covid-19 in Renal Transplant Recipients: Experience of Lithuania

    M. Miglinas, M. M. Janušaitė, E. Ašakienė, L. Vareikienė

  • Covid-19 in Solid Organ Transplantation (SOT): Results of the National Covid Cohort Collaborative (N3C)

    G. Agarwal1, A. Vinson2, R. Dai3, E. French4, S. Lee5, A. Olex4, A. Anzalone6, V. Madhira7, R. B. Mannon8

  • COVID-19 in the Kidney Transplant Waitlist Population

    A. C. Johnson1, C. P. Larsen1, H. Gebel2, R. Bray2

  • Covid-19 Incidence Was Initially Associated with Posttransplant Kidney Graft Failure

    A. Wey1, J. Miller1, D. Musgrove1, N. Salkowski1, M. Tabaka1, R. Hirose2, A. Massie3, D. Segev3, A. Israni1, J. Snyder1, B. Kasiske1

  • COVID-19 Infection in Kidney versus Non-kidney Solid Organ Transplant Recipients: A Single Center Study

    J. Schaenman1, H. Byford2, T. R. Grogan3, S. Fraschilla2, K. Meneses4, J. C. Alejos5, M. Rivera6, S. Saab7

  • Covid-19 Infections Post-liver and Kidney Transplantation in a Southern Ca Program

    M. E. de Vera1, J. Woloszyn2, S. Regmi2, R. Rattanavich2, M. Rakoski2, M. Lin2, P. Mehta2, A. Kore2, J. Weissman2, C. Martens2, T. Phan2, B. Jerez-Aguilar2, M. Robinson2, E. Wells2, R. Villicana2, M. Nguyen2

  • COVID-19 Potential Donor Derived Transmission Events Investigations: Early DTAC Experience

    R. La Hoz, A. Agarwal, S. Aslam, K. Dunn, J. Goldman, D. Levine, C. Marboe, G. F. Marklin, S. M. Pouch, M. Rana, R. Razonable, H. L. Stevenson, H. Te, A. E. Woolley, M. Michaels, L. Danziger-Isakov

  • COVID-19 Presentation and Severity Within One Year of Pancreas and Kidney Transplantation

    H. Sarumi, J. Fisher, B. Johnson, T. Pruett

  • Covid-19 Reinfection in a Kidney Transplant Patient

    Z. Saeed Zafar, D. Malhotra

  • Covid-19 Related Deaths Across the U.S. in Kidney Transplant Recipients

    K. Goli, N. T. Galvan, R. Cotton, J. A. Goss, C. A. O'Mahony, A. Rana

  • Covid-19 Severity within One Year of Liver, Pancreas and Kidney Transplantation

    H. Sarumi, J. Fisher, B. Johnson, T. Pruett

  • COVID-19 Transmission within One Year from Pancreas and Kidney Recipients

    H. Sarumi, J. Fisher, B. Johnson, T. Pruett

  • Covid-19-related Knowledge, Health Behaviors and Attitudes Towards Telemedicine and Emergency Visits in a Population of Kidney Transplant (KTx) Recipients

    A. Lin, M. Saw-Aung, W. Yang, G. Udod, A. Imas, M. Markell

  • Creating a Culturally Sensitive Report Card for African American Kidney Transplant Candidates: Preliminary Results from Pilot Interviews and Focus Groups

    W. T. McKinney1, M. Bruin2, B. Kasiske3, A. Matas4, A. K. Israni3

  • Creating a Lung Transplant Program Search Tool Tailored to Patient Characteristics

    W. T. McKinney1, C. R. Schaffhausen1, M. Bruin2, S. Chu2, J. Snyder3, M. Hertz4, M. Valapour5, B. Kasiske6, A. Israni1

  • Creating Efficiency in the Kidney Transplant Listing: Can We Streamline Candidate Ineligibility?

    A. Vijay, N. Langford, K. Atiemo, S. Giusti, M. Killackey, H. Jeon, A. S. Paramesh

  • Creatinine Reduction Ratio at 2 Postoperative Day as a Predicting Factor of Long-Term Outcomes After Living Donor Kidney Transplantation

    Y. Kinoshita, T. Shinzato, T. Shimizu, D. Iwami

  • CRISPR Screens to Map CTLA-4 Regulatory Networks in Primary Human T Cells

    O. Shaked1, J. Freimer1, J. Pritchard2, A. Marson1

  • Criteria and Practice Patterns for Accepting Living Donors with Prior Covid-19: A National Survey

    A. Jawed1, M. Y. Jan2, N. Barros2, O. Adebiyi2, A. Diez3, J. Fridell2, W. Goggins2, M. Yaqub2, M. A. Mujtaba4, T. Taber2, V. Kumar5, K. Lentine6, A. Sharfuddin2

  • Cross-Circulation for Extracorporeal Liver Support in a Swine Model

    W. K. Wu1, A. Tumen1, J. W. Stokes2, R. Ukita2, A. E. Hozain3, C. R. Flynn2, M. J. Lee3, J. R. Talackine2, N. L. Cardwell2, J. A. Reimer3, M. Pinezich3, C. Benson2, G. Vunjak-Novakovic3, S. P. Alexopoulos2, M. Bacchetta2

  • Cryptococcosis in Renal Transplant Recipients —An Analysis of United States Renal Data System Data

    M. E. Cervera-Hernandez, H. A. Yoon, L. Pirofski, V. Hemmige

  • CT-measured Cortical Volume Ratio is an Alternative to Nuclear Medicine Split Scan Ratio Among Living Kidney Donors

    J. Montgomery, C. Brown, A. Zondlak, K. Walsh, J. Kozlowski, A. Pinsky, E. Herriman, J. Sussman, Y. Lu, E. Stein, P. Shankar, R. Sung, K. Woodside

  • Current Opioid Utilization Practices of Kidney Transplant Centers in the United States: A National Survey of Institutional Practices

    A. Lichvar1, H. Kim1, A. Ingemi2, J. Jarrett1

  • Current Practices for Management and Treatment of COVID-19 in Immunocompromised Adults: A Survey of Institutions

    H. H. Nam1, S. Aslam2, O. Beaird3, G. Forrest4, M. Fung5, A. Limaye6, A. Multani3, J. Nelson7, R. Rakita6, L. Strasfeld8, J. Schaenman3

  • Cyp3a5 Extensive Metabolizer Phenotype May be Associated with an Increase in Class 2 Donor Specific Antibodies and Antibody-Mediated Rejection

    S. Mirza1, N. Wilson2, J. Van Zyl2, P. Nguyen2, T. Sam2, S. Hall2, M. Askar2, R. Patel2

  • Cytomegalovirus (CMV) D+/R- Serostatus is Independently Associated with Mortality and Graft Loss After Liver Transplantation (LTx)

    P. Vutien, J. Perkins, S. Biggins, J. Reyes, A. Limaye

  • Cytomegalovirus Infection Among Adult Kidney Transplant Recipients: Findings From the USRDS-medicare Linked Database Study

    A. Raval1, M. Ganz2, S. Alam2, Y. Tang1, C. Santos3

  • Cytomegalovirus Nephritis: Epidemiology and Outcomes of an Uncommon Diagnosis

    K. J. Swanson, A. Djamali, A. Ghaffar, F. Aziz, N. Garg, M. Mohamed, D. A. Mandelbrot, M. Jorgensen, S. Parajuli

Jump to:  View All • a b [c] d e f g h i j k l m n o p q r s t u v w x y z

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences